Cargando…
Increased concentration of two different advanced glycation end-products detected by enzyme immunoassays with new monoclonal antibodies in sera of patients with rheumatoid arthritis
BACKGROUND: Levels of pentosidine (representative of advanced glycation end-products) in sera of patients with rheumatoid arthritis are increased when compared with sera of other diagnoses or healthy controls. These levels have been reported to correlate with clinical indices of rheumatoid arthritis...
Autores principales: | Vytášek, Richard, Šedová, Liliana, Vilím, Vladimír |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2881016/ https://www.ncbi.nlm.nih.gov/pubmed/20433772 http://dx.doi.org/10.1186/1471-2474-11-83 |
Ejemplares similares
-
Pharmacogenomics of Monoclonal Antibodies for the Treatment of Rheumatoid Arthritis
por: Lim, Sung Ho, et al.
Publicado: (2022) -
Emerging therapies in rheumatoid arthritis: focus on monoclonal antibodies
por: Senolt, Ladislav
Publicado: (2019) -
Surface plasmon resonance unveils important pitfalls of enzyme-linked immunoassay for the detection of anti-infliximab antibodies in patients’ sera
por: Beeg, Marten, et al.
Publicado: (2021) -
Rheumatoid arthritis sera antibodies to citrullinated collagen type II bind to joint cartilage
por: Li, Qixing, et al.
Publicado: (2022) -
Monoclonal IgA Antibodies for Aflatoxin Immunoassays
por: Ertekin, Özlem, et al.
Publicado: (2016)